Skip to content

Efficacy and Safety of Superior Trunk Block Versus Interscalene Block for Post-operative Analgesia in Shoulder Surgeries

Efficacy and Safety of Superior Trunk Block Versus Interscalene Block for Post-operative Analgesia in Shoulder Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05978427
Enrollment
40
Registered
2023-08-07
Start date
2023-05-01
Completion date
2023-12-01
Last updated
2024-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior Trunk Block Versus Interscalene Block for Post-operative Analgesia in Shoulder Surgeries

Keywords

superior trunk block, interscalene block

Brief summary

Efficacy and safety of superior trunk block versus interscalene block for post-operative analgesia in shoulder surgeries

Detailed description

The interscalene brachial plexus block is the gold standard analgesic technique for surgery involving the shoulder and upper arm. However, due to its complications as hemidiaphragmatic paralysis, the superior trunk block was developed in an attempt to reduce major complications.The utility of the superior trunk block has yet to be studied in shoulder surgeries.

Interventions

PROCEDUREinterscalene block

will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in interscalene block.

will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in superior trunk block.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients American Society of Anaesthesiologists physical status (ASA) is I to II. * Both genders. * Aged group from 21 to 50 years old. * Patients electively scheduled for shoulder surgery under general anesthesia with normal coagulation profile.

Exclusion criteria

* Refusal of the procedure or participation in the study. * Any history or evidence of coagulopathy. * Evidence of infection at injection site. * Allergy to study drugs. * Patients with pulmonary severe respiratory disease. * Herniated cervical disc or cervical myelopathy. * Pre-existing neuropathy of the operative limb

Design outcomes

Primary

MeasureTime frameDescription
diaphragmatic paralysis postoperativewithin 24 hours after surgeryo The incidence of diaphragmatic paralysis postoperative assessed by Diaphragmatic excursion distance by Ultrasound

Secondary

MeasureTime frameDescription
Post operative nausea and vomitingwithin 24 hours after surgeryincidence of post operative complications as nausea an vomiting
analgesic efficacywithin 24 hours after surgeryo Analgesic efficacy of the nerve block in both groups by assessing postoperative pain vas score
rescue analgesiawithin 24 hours after surgeryThe total amount of rescue analgesia used

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026